Skip to Main Content

Paper Details

Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.
Eur Urol Focus
1
2023
BCL2 Family, BCL2 family, BCL2 family members, EGFR, PDC, PDCs, Papillary, Papillary Renal Cancer, Patient, Patient-derived, Patient-derived Papillary Renal Cancer Cells, advanced papillary renal cell carcinoma, chromosomes 7, 16, and 17, kidney cancer, pRCC, pRCC PDCs, patient, patient-derived cell cultures, patient-derived cells, patients, tumour, tumours
Author NameAffiliation
Abdullah KahramanInstitute for Chemistry and Bioanalytics, University of Applied Sciences Northwestern Switzerland
Olli KallioniemiInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Karolinska Institutet
Holger MochUniversity Hospital Zurich and University of Zurich
Holger MochUniversity Hospital Zurich and University of Zurich
  • 1 - 4

Datasets

Release 1.2